semaglutides

Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Mon, 11/26/18 - 09:56 am
Novo Nordisk
semaglutides
type 2 diabetes
clinical trials
cardiovascular outcomes